Dataset Information


Arterial spin labeled MRI in prodromal Alzheimer's disease: A multi-site study.

ABSTRACT: We examined differences in cerebral blood flow (CBF) measured by Arterial Spin Labeled perfusion MRI (ASL MRI) across the continuum from cognitively normal (CN) older adults to mild Alzheimer's Disease (AD) using data from the multi-site Alzheimer's Disease Neuroimaging Initiative (ADNI). Measures of CBF, in a predetermined set of regions (meta-ROI), and hippocampal volume were compared between CN (n = 47), patients with early and late Mild Cognitive Impairment [EMCI (n = 32), LMCI (n = 35)], and AD (n = 15). Associations between these measures and disease severity, assessed by Clinical Dementia Rating scale sum of boxes (CDR SB), were also assessed. Mean meta-ROI CBF was associated with group status and significant hypoperfusion was observed in LMCI and AD relative to CN. Hippocampal volume was associated with group status, but only AD patients had significantly smaller volumes than the CN. When examining the relationship between these measures and disease severity, both were significantly associated with CDR SB and appeared to provide independent prediction of status. In light of the tight link between CBF and metabolism, ASL MRI represents a promising functional biomarker for early diagnosis and disease tracking in AD and this study is the first to demonstrate the feasibility in a multi-site context in this population. Combining functional and structural measures, which can be acquired in the same scanning session, appears to provide additional information about disease severity relative to either measure alone.

PROVIDER: S-EPMC3777751 | BioStudies |

REPOSITORIES: biostudies

Similar Datasets

| S-EPMC3235355 | BioStudies
| S-EPMC6869162 | BioStudies
| S-EPMC6957781 | BioStudies
| S-EPMC4562004 | BioStudies
| S-EPMC5842754 | BioStudies
| S-EPMC5491625 | BioStudies
| S-EPMC6309706 | BioStudies
| S-EPMC6627731 | BioStudies
| S-EPMC6558180 | BioStudies
| S-EPMC8639710 | BioStudies